Adbry ratings & reviews

Tralokinumab
Company: Leo Pharma
Brand: Adbry
Drug class: Antineoplastic and Immunomodulating Agents
+6 more
Antineoplastic and Immunomodulating Agents, Dermatologicals, Agents that Suppress the Immune System, Nonsteroidals For Inflammatory Skin Disorders, Interleukin-13 (IL-13) Inhibitors, Systemic Dermatitis Agents, Dermatitis Monoclonal Antibodies

Sermo AI Overview

  • Adbry is regarded as effective for treating moderate to severe eczema and atopic dermatitis, although it is not typically the first-choice treatment. Efficacy ratings vary, averaging around 3.7 out of 5, indicating mixed experiences among patients.
  • Adbry's access may be limited in various regions, creating barriers to treatment for those in need, particularly affected by insurance limitations and physician preferences for other therapies as initial treatments.
  • Despite some dermatologists rating the safety and tolerability of Adbry positively, many patients face significant challenges with access and insurance coverage, which impacts overall treatment availability.
  • Reports indicate that while Adbry shows effectiveness, concerns about side effects lead to caution among healthcare professionals, resulting in variability in how well patients adhere to the prescribed treatment.
Based on insights from Sermo’s triple verified physicians

Description

Adbry contains the active ingredient tralokinumab-ldrm, which is a human IgG4 monoclonal antibody and interleukin-13 antagonist. It is available as a sterile, preservative-free solution for subcutaneous injection, supplied in single-dose prefilled syringes or autoinjectors. The prefilled syringe delivers 150 mg per mL, while the autoinjector delivers 300 mg in 2 mL. Key inactive ingredients include acetic acid, polysorbate 80, sodium acetate trihydrate, and sodium chloride.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

This medication is injected under the skin. You will be taught how to prepare and give it. Take it as directed on the prescription label. Keep taking it unless your care team tells you to stop. It is important that you put your used needles and syringes in a special sharps container. Do not put them in a trash can. If you do not have a sharps container, call your pharmacist or care team to get one. This medication comes with INSTRUCTIONS FOR USE. Ask your pharmacist for directions on how to use this medication. Read the information carefully. Talk to your pharmacist or care team if you have questions. Talk to your care team about the use of this medication in children. While it may be prescribed for children as young as 12 years for selected conditions, precautions do apply.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

If you miss a dose, take it as soon as you can, even if it is almost time to take your next scheduled dose. Take the next dose at the normal time.

Where should I keep my medication?

Keep out of the reach of children and pets. Store in a refrigerator or at room temperature between 20 and 25 degrees C (68 and 77 degrees F). Do not expose to extreme heat or cold. Keep this medication in the original container until you are ready to take it. Protect from light. Refrigeration (preferred): Store it in the refrigerator. Remove the dose from the container about 30 minutes before it is time for you to take it. Get rid of any unused medication after the expiration date. Room Temperature: This medication may be stored at room temperature for up to 14 days. Do not put it back in the refrigerator after reaching room temperature. If it is stored at room temperature, get rid of any unused medication after 14 days or after it expires, whichever is first. To get rid of medications that are no longer needed or have expired: -Take the medication to a medication take-back program. Check with your pharmacy or law enforcement to find a location. -If you cannot return the medication, ask your pharmacist or care team how to get rid of this medication safely.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible: -Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat -Eye pain, redness, irritation, or discharge with blurry or decreased vision Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome): -Pain, redness, or irritation at injection site

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions: -Infection caused by a parasite, such as a hookworm -Recent or upcoming vaccine -An unusual or allergic reaction to tralokinumab, other medications, foods, dyes, or preservatives -Pregnant or trying to get pregnant -Breastfeeding

What may interact with this medication?

-Live virus vaccines

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Visit your care team for regular checks on your progress. It may be some time before you see the benefit from this medication. This medication can decrease the response to a vaccine. If you need to get vaccinated, tell your care team if you have received this medication. Extra booster doses may be needed. Talk to your care team to see if a different vaccination schedule is needed.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence